Clinical Trial: Neuroprotective Effects of Endovascular Therapy Combined with Edaravone Dexborneol on Acute Large-Core Ischemic Stroke: Modulation of the NLRP3 Inflammasome Pathway (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Neuroprotective Effects of Endovascular Therapy Combined with Edaravone Dexborneol on Acute Large-Core Ischemic Stroke: Modulation of the NLRP3 Inflammasome Pathway'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130373

Registration Time: 2026/08/19

Type: Interventional study

Primary Sponsor: Quanzhou first Hospital,Fujian

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=331596

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Neuroprotective Effects of Endovascular Therapy Combined with Edaravone Dexborneol on Acute Large-Core Ischemic Stroke: Modulation of the NLRP3 Inflammasome Pathway (China)